<DOC>
	<DOCNO>NCT02478879</DOCNO>
	<brief_summary>The purpose study determine two delivery method Parathyroid Hormone ( PTH ) prefer patient 14 day use .</brief_summary>
	<brief_title>A Study Determine Patient Preference Between Zosano Pharma Parathyroid Hormone ( ZP-PTH ) Patch Forteo Pen</brief_title>
	<detailed_description>The purpose study determine two delivery method PTH prefer patient 14 day use . Patient preference determine mean patient questionnaire end treatment period final questionnaire treatment period complete . Adverse event also collect .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Postmenopausal prior diagnosis osteoporosis Significant health issue previous use teriparatide History Paget 's disease</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>